Kim A Reiss (Reiss Binder), MD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-305
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-360-0735
Fax: 215-662-4646
Fax: 215-662-4646
Education:
BA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Permanent linkBA (Psychology)
Colby College, 2002.
Post BA (Pre-Med)
Johns Hopkins University , 2003.
MD (Medicine)
Penn State College of Medicine , 2008.
Selected Publications
Kim A. Reiss, MD; Sung Chul Hong, MS; Anup K. Kasi, MD; Eileen M. O’Reilly, MD; Shishir K Maithel, MD; Xin Yao, MD; Stanley R Hamilton, MD; Ben Boursi, MD; Michael J. Pishvaian, MD; Samuel J. Klempner, MD; Susan M. Domchek, MD; Paul Catalano, ScD; Elena G. Chiorean, MD; Philp A. Philip, MD; Peter J. O’Dwyer, MD: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation: ECOG-ACRIN EA2192. ASCO GI, San Francisco, CA Jan 2023.Timothy J Brown MD; Arielle Yablonovitch, PhD; Jennifer Yen, PhD; Lesli A. Kiedrowski, MS MPH; Erica Carpenter, PhD MBA; Katherine Nathanson, MD; Susan M. Domchek, MD and Kim A Reiss, MD: The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib. ASCO GI, San Francisco, CA Jan 2023.
Thatcher R. Heumann, Marina Baretti, Elizabeth A. Sugar, Jennifer N. Durham, Sheila Linden, Tamara Y. Lopez-Vidal, James Leatherman, Leslie Cope, Anup Sharma, Colin D. Weekes, Peter J. O’Dwyer, Kim A. Reiss, Dulabh K. Monga, Nita Ahuja & Nilofer S. Azad : A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Clinic Epigenetics Dec 2022.
William Chapin and Kim A. Reiss: PARP Inhibitors and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 36(5): 1019-1032, Oct 2022.
Thomas B. Karasic, Timothy J Brown, Charles J. Schneider, Ursina R. Teitelbaum, Kim A. Reiss, Tara C. Mitchell, Ryan C. Massa, Mark H. O’Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi K. Amaravadi, Peter J O’Dwyer: Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer. The Oncologist 27(9): 716-e689, Sep 2022.
Kim A. Reiss; Rosemarie Mick; Ursina Teitelbaum; Mark O’Hara; Charles Schneider; Ryan Massa; Thomas Karasic; Rashmi Tondon; Chioma Onyiah; Mary Kate Gosselin; Alyssa Donze; Susan M. Domchek; Robert H. Vonderheide: Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase Ib/II trial. Lancet Oncology 23(8): 1009-1020, Aug 2022.
William J. Chapin, MD, Jacob E. Till, MD, PhD, Wei-Ting Hwang, PhD, Jennifer R. Eads, MD, Thomas B. Karasic, MD, Peter J. O’Dwyer, MD, Charles J. Schneider, MD, Ursina R. Teitelbaum, MD, Janae Romeo, MBE, BA, Taylor A. Black, BA, Theresa E. Christensen, BA, Colleen Redlinger Tabery, BA, Amanda Anderson, PhD, Megan Slade, BS, Michael LaRiviere, MD, Stephanie S. Yee, MS, MBA, Kim A. Reiss, MD, Mark H. O’Hara, MD, Erica L. Carpenter, MBA, PhD: Multi-analyte prognostic signature including circulating tumor DNA and circulating tumor cells in patients with advanced pancreatic adenocarcinoma. JCO Precision Oncology 6: e2200060, Jul 2022 Notes: doi: 10.1200/PO.22.00060.
Brennan Decker, Susan M. Domchek, Kate Nathanson, Shannon Bailey, Natalie Danziger, James Thornton, Mark Hartman, Chenming Cui1, Lei Yang, Smruthy Sivakumar, Russell Madison1, Ethan Sokol, Alexa B. Schrock, Bahar Yilmazel, Douglas A Mata, Christine Vietz, Jeffrey S. Ross, Julia A. Elvin, Geoffrey R. Oxnard, Kim A. Reiss : Landscape of homologous recombination reversion mutations in pancreaticobiliary malignancies ASCO 2022, Chicago, IL June 2022 Notes: "Poster Presentation"
Kim A. Reiss, MD; Rosemarie Mick, MS; Ursina Teitelbaum, MD; Mark O’Hara, MD; Charles Schneider, MD; Ryan Massa, MD; Thomas Karasic, MD; Chioma Onyiah; Mary Kate Gosselin, RN; Alyssa Donze, RN; Susan M. Domchek, MD; Robert H. Vonderheide, MD, DPhil : A Randomized Phase Ib/II Study of Niraparib (Nira) plus Nivolumab (Nivo) or Ipilimumab (Ipi) in Patients (Pts) with Platinum-Sensitive Advanced Pancreatic Cancer (aPDAC) ASCO 2022, Chicago, IL Jun 2022 Notes: "Oral Presentation"
Susan M. Domchek, Kim A. Reiss, Kate Nathanson, Shannon Bailey, Natalie Danziger, James Thornton, Mark Hartman, Chenming Cui, Lei Yang, Matthew Margolis, Erica Gornstein, Ethan Sokol, Douglas I. Lin, Alexa B. Schrock, Douglas A. Mata, Christine Vietz, Jeffrey S. Ross, Geoffrey R. Oxnard, Julia A. Elvin, Brennan Decker : Landscape of homologous recombination reversion mutations in gynecologic malignancies ASCO 2022, Chicago, IL June 2022 Notes: "Poster Presentation"